loading
Precedente Chiudi:
$13.70
Aprire:
$13.59
Volume 24 ore:
6,091
Relative Volume:
0.09
Capitalizzazione di mercato:
$346.75M
Reddito:
$26.00M
Utile/perdita netta:
$-219.71M
Rapporto P/E:
-0.2705
EPS:
-49.8
Flusso di cassa netto:
$-51.37M
1 W Prestazione:
+10.59%
1M Prestazione:
+26.12%
6M Prestazione:
-29.95%
1 anno Prestazione:
-21.59%
Intervallo 1D:
Value
$13.26
$13.81
Intervallo di 1 settimana:
Value
$12.56
$14.56
Portata 52W:
Value
$8.46
$26.50

Cartesian Therapeutics Inc Stock (RNAC) Company Profile

Name
Nome
Cartesian Therapeutics Inc
Name
Telefono
301-348-8698
Name
Indirizzo
7495 NEW HORIZON WAY, FREDERICK
Name
Dipendente
66
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
RNAC's Discussions on Twitter

Confronta RNAC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RNAC
Cartesian Therapeutics Inc
13.36 345.97M 26.00M -219.71M -51.37M -49.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
464.44 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
556.22 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.63 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.75 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.08 31.54B 3.81B -644.79M -669.77M -6.24

Cartesian Therapeutics Inc Stock (RNAC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-09 Iniziato Wedbush Outperform
2024-12-19 Iniziato BTIG Research Buy
2024-08-06 Iniziato TD Cowen Buy
2024-07-02 Downgrade Oppenheimer Outperform → Perform
2024-06-04 Iniziato Oppenheimer Outperform
2024-05-24 Iniziato Mizuho Buy
2024-04-23 Reiterato H.C. Wainwright Buy
2024-04-23 Iniziato Leerink Partners Outperform
2023-08-18 Downgrade SVB Securities Outperform → Market Perform
2022-06-14 Reiterato Needham Buy
2022-06-06 Iniziato SVB Leerink Outperform
2021-06-15 Iniziato BTIG Research Buy
2021-01-26 Aggiornamento Mizuho Neutral → Buy
2020-10-01 Downgrade Mizuho Buy → Neutral
2020-10-01 Downgrade William Blair Outperform → Mkt Perform
2020-06-12 Downgrade Stifel Buy → Hold
2020-04-28 Iniziato H.C. Wainwright Buy
2020-01-29 Iniziato Cantor Fitzgerald Overweight
2020-01-21 Iniziato William Blair Outperform
2018-06-27 Iniziato Janney Buy
2017-03-30 Reiterato UBS Buy
Mostra tutto

Cartesian Therapeutics Inc Borsa (RNAC) Ultime notizie

pulisher
06:54 AM

How to use a screener to detect Cartesian Therapeutics Inc. breakoutsPortfolio Booster Strategy with Trend Confidence - Newser

06:54 AM
pulisher
04:39 AM

How Cartesian Therapeutics Inc. stock performs during market volatilityOversold Reversal Picks with Buy Zone - Newser

04:39 AM
pulisher
04:17 AM

What makes Cartesian Therapeutics Inc. stock price move sharplyFree Weekly Hot Picks With Buy Confidence - Newser

04:17 AM
pulisher
03:48 AM

Why Cartesian Therapeutics Inc. stock attracts strong analyst attentionFree Capital Preserving Trade Plan Templates - Newser

03:48 AM
pulisher
Jul 28, 2025

How strong is Cartesian Therapeutics Inc. company’s balance sheetSmart Portfolio Ideas For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 21:34:06 - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

Cartesian Therapeutics Inc.’s Price Action Aligns with Quant SignalsLow Risk Equity Screener With Results Shared - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Technical signs of recovery in Cartesian Therapeutics Inc.Short-Term Swing Opportunity Summary Sheet - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Price action breakdown for Cartesian Therapeutics Inc.Buy and Hold Strategy for Capital Safety - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How does Cartesian Therapeutics Inc. generate profit in a changing economySuperior portfolio returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How to integrate Cartesian Therapeutics Inc. into portfolio analysis tools Swing Trade Picks with High Potential - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What are Cartesian Therapeutics Inc. company’s key revenue driversExceptional market positioning - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Cartesian Therapeutics Inc. stock overvalued or undervaluedAchieve consistent profits with proven methods - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Cartesian Therapeutics Inc. stockInvest confidently with data-driven strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

New Product Launches: Will They Boost Cartesian Therapeutics Inc. Stock in 2025Free Stock Market Real-Time Monitoring - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Interest Rate Changes Impact Cartesian Therapeutics Inc. Stock PerformanceControlled Risk High Reward Plan - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

What analysts say about Cartesian Therapeutics Inc. stockBreakout portfolio performance - jammulinksnews.com

Jul 26, 2025
pulisher
Jul 25, 2025

Cartesian Therapeutics, Inc. (RNAC) Moves 9.9% Higher: Will This Strength Last? - MSN

Jul 25, 2025
pulisher
Jul 25, 2025

When is the best time to buy Cartesian Therapeutics Inc. stockSuperior investment outcomes - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Cartesian Therapeutics Inc. stock priceOutstanding trading profits - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Cartesian Therapeutics Inc. stock a good hedge against inflationSuperior risk-adjusted returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Is Cartesian Therapeutics Inc. a good long term investmentHigh-profit stock alerts - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate - Benzinga

Jul 24, 2025
pulisher
Jul 23, 2025

Cartesian Therapeutics Inc. Stock Analysis and ForecastFree Daily Trading Room Entry - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Chronic Refractory Gout Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Amgen, Cartesian Therapeutics, Swedish Orphan Biovitrum, Arthrosi Therapeutics, TaiwanJ Pharma - Barchart.com

Jul 23, 2025
pulisher
Jul 22, 2025

Multiple Myeloma Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis CASI Pharmaceuticals, Carsgen Therapeutics, Cartesian Therapeutics - Menafn.com

Jul 22, 2025

Cartesian Therapeutics Inc Azioni (RNAC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Cartesian Therapeutics Inc Azioni (RNAC) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
English Emily
Chief Operations Officer
Apr 15 '25
Option Exercise
3.30
7,500
24,750
47,726
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
10.47
48,595
508,751
620,175
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
9.43
41,782
393,947
571,580
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
10.77
36,338
391,455
656,513
SPRINGER TIMOTHY A
Director
Apr 10 '25
Buy
10.47
8,575
89,773
8,637,273
SPRINGER TIMOTHY A
Director
Apr 09 '25
Buy
9.43
7,373
69,517
8,628,698
SPRINGER TIMOTHY A
Director
Apr 11 '25
Buy
10.77
6,412
69,074
8,643,685
SPRINGER TIMOTHY A
Director
Mar 20 '25
Buy
15.59
54,889
855,593
8,621,325
SPRINGER TIMOTHY A
Director
Mar 19 '25
Buy
14.97
20,234
302,962
8,566,436
SPRINGER TIMOTHY A
Director
Mar 18 '25
Buy
14.42
14,740
212,599
8,546,202
$22.70
price down icon 1.47%
$37.19
price up icon 0.34%
$103.58
price up icon 1.90%
$27.09
price down icon 1.28%
$111.66
price down icon 1.02%
biotechnology ONC
$305.08
price up icon 3.52%
Capitalizzazione:     |  Volume (24 ore):